Novartis Pharmaceuticals Corporation

Novartis Pharmaceuticals Corporation engages in the development, manufacture, marketing, and sale of prescription drugs. The company’s products are primarily used for the treatment of cardiovascular, metabolic, cancer, organ transplantation, central nervous system, gastrointestinal and respiratory, and dermatological diseases. It offers various products that are used for the treatment of hypocalcaemia, osteoarthritis and rheumatoid arthritis, schizophrenic patients, vasomotor symptoms associated with menopause, Parkinson's disease, recurrent herpes labialis, and acute iron intoxication. The company’s products are also used for the treatment of hypertension, eczema, overactive bladder, vasomotor symptoms associated with menopause, dementia of Alzheimer's type, iron overload, recurrent genital herpes and shingles, metastatic breast cancer, asthma, chronic myeloid leukemia, foot fungus, leprosy, atherosclerosis vascular diseases, postmenopausal osteoporosis, and bone metastasis in various tumor types. In addition, it offers products for the management of postpartum hemorrhage; immunosuppressive therapy and management of organ transplant recipients; and treatment of metastatic renal cell carcinoma and metastatic melanoma. The company was founded in 1996 and is headquartered in East Hanover, New Jersey with additional offices in Florham Park, New Jersey; and Suffern, New York. Novartis Pharmaceuticals Corporation is a subsidiary of Novartis AG.